The Spring Research Festival, Fort Detrick’s annual scientific showcase, is seeking participants. NCI Frederick and Frederick National Laboratory staff (including those located at the Advanced Technology Research Facility) are encouraged to participate in one or more of the festival’s functions. Registration for participants, namely presenters and judges, is open until April 5.

The cancer community will come together for a two-day conference designed to celebrate Black contributions in cancer research and to connect future investigators and collaborators, in order to pave the way for the next generation of Black cancer research professionals. Black in Cancer, a U.S./U.K.-based organization, and the Frederick National Laboratory for Cancer Research are co-hosts of the 2024 Black in Cancer Conference, set for June 20–21 at the Natcher Conference Center on the National Institutes of Health campus in Bethesda.

Experiencing a persistent cough, tight chest, and sinus discomfort can be uncomfortable. When you have these symptoms, it’s natural to seek medication to help ease your symptoms and promote healing. As a nurse practitioner, I have faced the dilemma of finding suitable over-the-counter cold remedies without a clear, evidence-based answer. Standing in the cold and sinus aisle, the abundance of products is overwhelming. To make an informed decision, I considered the underlying causes of sinus congestion, including common colds, nasal irritants, and environmental triggers.

Visualizing protein structures in three dimensions instead of two has given scientists new insights into biological processes, and now artificial intelligence is adding the capacity to predict molecular behaviors that could potentially be borne out in laboratory studies. For Kylie Walters, Ph.D., a structural biologist with the NCI Center for Cancer Research in Frederick, artificial intelligence, or AI, has revolutionized the way her laboratory works.

Frederick-area biotechnology professionals got an inside look at advances in mass spectrometry as part of the quarterly Biotech Connector Series at the Frederick National Laboratory for Cancer Research.